---
figid: PMC4549733__toxins-07-02918-g003
figtitle: Simplified overview (a modified schema from ) of some molecular events (and
  potential drug targets) involved in bacterial autophagy
organisms:
- Escherichia coli
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Pseudomonas aeruginosa
- Helicobacter pylori
- Bacillus subtilis
- Salmonella enterica subsp. enterica serovar Typhimurium
- Listeria monocytogenes
- Escherichia coli K-12
- Vibrio cholerae
- Streptococcus pyogenes
- Bacillus anthracis
- Shigella flexneri
- Francisella tularensis
- Streptomyces hygroscopicus
- Serratia marcescens
- Streptococcus sp. group A
- Yersinia pestis
- Burkholderia pseudomallei
- Yersinia pseudotuberculosis
- Bordetella pertussis
- Helicobacter pylori SS1
- Burkholderia pseudomallei THE
- Saccharomyces cerevisiae
- Cryptococcus neoformans var. grubii
- Euphorbia fischeriana
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
- prion
- H5N1 subtype
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Arabidopsis thaliana
pmcid: PMC4549733
filename: toxins-07-02918-g003.jpg
figlink: /pmc/articles/PMC4549733/figure/toxins-07-02918-f003/
number: F3
caption: A simplified overview (a modified schema from []) of some molecular events
  (and potential drug targets) involved in bacterial autophagy. For example, the increase
  in intracellular calcium concentration leads to thea activation of calpains, which
  inhibit autophagy. Inhibitors of calcium or calpain could therefore interfere with
  the autophagic pathway. Inflammatory mediators, such as cytokines, trigger PI3K
  activation, leading to a decrease in autophage through effects on mTORC1. PI3K inhibitors
  or rapamycin treatment to inhibit mTORC1 enhances autophagy. Glucose starvation,
  which can be induced by stress, activates AMPK, leading to the inhibition of mTORC1
  and the stimulation of autophagy. Membrane damage by pore-forming toxins induces
  starvation responses []. Loss of cellular potassium from perforated cells leads
  to the failure of nutrient transport and transient drop of ATP, thus activating
  cellular nutrient and energy sensors GCN2 and AMPK, subsequent phosphorylation of
  ElF2α and deactivation of mTORC1. Bacterial toxins, such as those with adenylate
  cyclase activity (ACs), enhance cAMP production, leading to an activation of the
  inositol pathway. InsP3 inhibits autophagy, and drugs such as lithium (Li) and valproic
  acid block the inositol cycle, restoring autophagy. The overproduction of cAMP activates
  the PKA pathway, potentially impairing the localization of Atg1 and Atg13 to the
  phagophore assembly site, resulting in defective autophagy. Motifs from bacteria
  or endotoxins are recognized by TLRs, which activate numerous pathways. For example,
  those triggering the HO-1 pathway can activate autophagy by activating mitochondrial
  ROS and p38 MAPK. However, endotoxins can induce oxygen stress and ROS overproduction,
  via the TLRs, either enhancing or inhibiting autophagy. Antioxidants, such as catalase
  and resveratrol, strongly enhance or restore the autophagic pathway.
papertitle: 'Interactions between Autophagy and Bacterial Toxins: Targets for Therapy?.'
reftext: Jacques Mathieu. Toxins (Basel). 2015 Aug;7(8):2918-2958.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9437838
figid_alias: PMC4549733__F3
figtype: Figure
redirect_from: /figures/PMC4549733__F3
ndex: 22157927-dede-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4549733__toxins-07-02918-g003.html
  '@type': Dataset
  description: A simplified overview (a modified schema from []) of some molecular
    events (and potential drug targets) involved in bacterial autophagy. For example,
    the increase in intracellular calcium concentration leads to thea activation of
    calpains, which inhibit autophagy. Inhibitors of calcium or calpain could therefore
    interfere with the autophagic pathway. Inflammatory mediators, such as cytokines,
    trigger PI3K activation, leading to a decrease in autophage through effects on
    mTORC1. PI3K inhibitors or rapamycin treatment to inhibit mTORC1 enhances autophagy.
    Glucose starvation, which can be induced by stress, activates AMPK, leading to
    the inhibition of mTORC1 and the stimulation of autophagy. Membrane damage by
    pore-forming toxins induces starvation responses []. Loss of cellular potassium
    from perforated cells leads to the failure of nutrient transport and transient
    drop of ATP, thus activating cellular nutrient and energy sensors GCN2 and AMPK,
    subsequent phosphorylation of ElF2α and deactivation of mTORC1. Bacterial toxins,
    such as those with adenylate cyclase activity (ACs), enhance cAMP production,
    leading to an activation of the inositol pathway. InsP3 inhibits autophagy, and
    drugs such as lithium (Li) and valproic acid block the inositol cycle, restoring
    autophagy. The overproduction of cAMP activates the PKA pathway, potentially impairing
    the localization of Atg1 and Atg13 to the phagophore assembly site, resulting
    in defective autophagy. Motifs from bacteria or endotoxins are recognized by TLRs,
    which activate numerous pathways. For example, those triggering the HO-1 pathway
    can activate autophagy by activating mitochondrial ROS and p38 MAPK. However,
    endotoxins can induce oxygen stress and ROS overproduction, via the TLRs, either
    enhancing or inhibiting autophagy. Antioxidants, such as catalase and resveratrol,
    strongly enhance or restore the autophagic pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - aa
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - AcCoAS
  - Acsl
  - 18w
  - tok
  - tlr-2
  - Akt
  - adp
  - ATPsynbeta
  - Atpalpha
  - Gcn2
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Itpr
  - eIF2alpha
  - eIF2A
  - Crtc
  - Ho
  - SNF4Agamma
  - AMPKalpha
  - Tu
  - MKP-4
  - p38b
  - rl
  - lic
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Cat
  - H2-Aa
  - Pik3r1
  - Acsl1
  - Acss2
  - Pla2g15
  - Akt1
  - Wdtc1
  - Mdga2
  - Akt2
  - Eif2ak4
  - Eif2a
  - Eif2s1
  - Hmox1
  - tu
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Decr1
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - FGD1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PLA2G15
  - ACSS2
  - ACCS
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - AKT1
  - AKT2
  - AKT3
  - WDTC1
  - ATP8A2
  - PTK2B
  - EIF2AK4
  - EIF2A
  - EIF2S1
  - MTOR
  - RPTOR
  - HMOX1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - GRAP2
  - AHSA1
  - POLDIP2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CYBA
  - CYBB
  - DUOX1
  - DUOX2
  - NCF1
  - NCF2
  - NCF4
  - NOX1
  - NOX3
  - NOX4
  - NOX5
  - RAC1
  - DECR1
  - Pik3cg
  - Svs4
  - Eif2b1
  - Prkaa2
  - AAS
  - VPS34
  - ACS
  - GCN2
  - TED4
  - CAT2
  - Epicatechins
  - Inositol
  - Valproic acid
  - Rapamycin
---
